InvestorNewsBreaks – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) to Participate in Upcoming Online Investor Conference
Dec 12, 2022
Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF), a clinical-stage biotechnology company focused on developing intravenous-infused psilocin (the active metabolite of psilocybin) for diseases with high unmet medical needs, will be presenting live at the VirtualInvestorConferences.com event; the conference is scheduled for Dec. 15, 2022. According to the announcement, Tryp Therapeutics CEO Jim Gilligan will present during the event. Gilligan’s presentation is slated to begin at 2 p.m. ET, and the presentation will include time set aside for a real-time Q&A session. In addition, company officials will be available for one-on-one meetings with investors on Dec. 16 and Dec. 19–Dec. 20. An archived webcast of the presentation will be available after the event.
To view the full presentation, visit https://ibn.fm/9f503
To view the full release, visit https://ibn.fm/sMa8A
About Tryp Therapeutics Inc.
Tryp Therapeutics is a clinical-stage biotechnology company focused on developing proprietary, novel formulations for the administration of psilocin in combination with psychotherapy to treat diseases with unmet medical needs. Tryp’s lead program, TRP-8803, is a proprietary formulation of IV-infused psilocin (the active metabolite of psilocybin) for the potential treatment of eating disorders, chronic pain, and other indications. The company has an ongoing phase 2a clinical trial for the treatment of binge eating disorder at the University of Florida and an upcoming phase 2a clinical trial with the University of Michigan for the treatment of fibromyalgia, both of which are utilizing TRP-8802 (synthetic, oral psilocybin) to demonstrate efficacy in these indications. Subsequent studies are expected to utilize TRP-8803, which has the potential to further improve efficacy, safety and patient experience. For more information about the company, please visit www.TrypTherapeutics.com.
NOTE TO INVESTORS: The latest news and updates relating to TRYPF are available in the company’s newsroom at https://ibn.fm/TRYPF
About InvestorWire
InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent.
As part of its service, InvestorWire provides coverage of noteworthy announcements. To further expand visibility of achievements being made throughout a multitude of sectors, InvestorWire’s syndication partners have extended the digital coverage to include individual broadcasts on financial websites and platforms visited by millions of investors daily.
For more information, please visit https://www.investorwire.com
Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer
InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]
InvestorWire is part of the InvestorBrandNetwork
More News
Ainsworth lets Gillingham players have it after Grimsby humiliation
Manager Gareth Ainsworth admitted he was as frustrated as the Gillingham fans after Saturday’s heavy defeat.
Matchday Live: Gillingham v Grimsby, Torquay v Maidstone, Ebbsfleet v Maidenhead, Folkestone v Farnborough
Follow today’s football action, including Gillingham’s match at home to Grimsby, in our live blog.
Chatham prepare for top-two test after Dulwich demolition
Chatham Town welcome second-placed Welling United to the Bauvill on Saturday looking to build on their midweek thrashing of Dulwich Hamlet.
Ainsworth wants new-look Gills to right Grimsby wrongs
Manager Gareth Ainsworth wants Gillingham to put past Grimsby misery behind them when the Mariners return to Priestfield on Saturday.
Injury boost as Gillingham players close in on comebacks
Gillingham captain Liam Gordon is one of four injured players closing in on a return to action.
‘We had a point to prove’ – Gillingham defender on Port Vale response
Defender Andy Smith admitted the Gills had let themselves down last weekend but was pleased with their response against Port Vale.
Football fixtures and results
Catch up with all the week’s football fixtures and results.
Ainsworth pinpoints moment Gillingham missed their chance
Gillingham manager Gareth Ainsworth was left to rue the big missed chance that let visitors Port Vale off the hook.
Report: Vale fightback denies Gillingham a home win
Gillingham had to settle for a point at home after Port Vale fought back from a goal down at Priestfield.
Gillingham boss reveals double selection blow hours before Port Vale clash
Gillingham were forced to make two changes to their team hours before Tuesday’s game against Port Vale.
Matchday Live: Gillingham v Port Vale, Ebbsfleet v Horsham
Follow tonight’s football action in our live blog, including Gillingham’s clash with Port Vale in League 2.
Captain confident ahead of top-flight return
Skipper Daniel Bell-Drummond is optimistic Kent can compete in County Championship Division 1 next summer.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.